Life after statin patent expiries

Nature Reviews Drug Discovery

Volumn 5, Issue 10, 2006, Pages 813-814

  Kidd, Jane ^a  

^a Wood Mackenzie   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; ATORVASTATIN; BILE ACID SEQUESTRANT; CHOLESTEROL; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MK 0524A; MURAGLITAZAR; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PRAVASTATIN; R 11658; ROSUVASTATIN; SIMVASTATIN; TESAGLITAZAR; TORCETRAPIB; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST CONTROL; DRUG COST; DRUG POTENCY; DYSLIPIDEMIA; HUMAN; LIVER TOXICITY; METABOLIC SYNDROME X; MUSCLE DISEASE; NEPHROTOXICITY; NONHUMAN; PATENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; RHABDOMYOLYSIS;

ANTICHOLESTEREMIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PATENTS; PATENTS AS TOPIC;

EID: 33749233854     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2156     Document Type: Article

References (2)

1. Consumer Reports. Best Buy Drugs. Treating Elevated Cholesterol and Heart Disease: The StatWns [online], (June 2006).
2. Nissen, S. E. et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 295, 1556-1565 (2006).